当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い
。オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル と 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得
Mohsen Haidary
The effective delivery of therapeutic agents to their target sites within the human body is a complex endeavor that relies on a myriad of intricate processes. Central to this challenge are the cellular gateways, specialized membrane transport proteins that regulate the movement of molecules across cell membranes. These gatekeepers, known as drug transporters, play a pivotal role in modulating the absorption, distribution, and excretion of drugs and other molecules. As such, understanding the functioning and regulation of drug transporters is paramount for optimizing therapeutic delivery strategies and enhancing drug efficacy. As the field continues to evolve, researchers are uncovering novel strategies to exploit drug transporters for targeted drug delivery and enhanced therapeutic outcomes. We discuss current approaches that leverage transporter-mediated drug delivery systems, including prodrugs, nanoparticles, and carrier-mediated transport.